Search General Info
Search Education
Search Partnering Companies

Nikolaos Tezapsidis

Bridgewater, New Jersey, United States
• Founder of Neurotez, Inc. and the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005.
• Led Neurotez, Inc. in developing a human Leptin product (Memtin) as a hormone replacement therapy for hypoleptinemic prodromal AD patients
• Raised funds primarily through non-dilutive capital sources (~$5mill) building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio.
• Small capital raises from non-accredited investors using Netcapital platform
• Partnered with MemtTrax for a new memory screening test for Alzheimer’s patients, and with Cytox for the application of a genetic screen to identify patients at risk for dementia.
• 18 years of hands-on biomedical research experience.
• Scientific consultant to biotechnology investors.
• Worked at several research organizations including: Columbia University, New York University Medical School
Speaking In
[On Demand]
Neurotez wants to overcome Alzheimer’s disease once and for all. Our novel approach focuses on…